Aurobindo Pharma receives US FDA approval for Cefixime for oral suspension USP
Cefixime for oral suspension is indicated for the treatment of adults and paediatric patients six months of age or older
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Merck appoints Udit Batra to head combined life science business
Batra has served as the Chief Executive Officer and President, Merck’s life science business Merck Millipore since March 2014
Suven initiates MAD studies in phase 1 clinical trial for investigational compound SUVN-G3031
SUVN-G3031 is a potent, selective, brain penetrant and orally active Histamine H3 inverse agonist being developed for the…
Quest Life Sciences acquires assets of FCRL
Quest will move the entire facility to Kandla, Gujarat in the special economic zone where it will set up a state-of-the-art BA/BE…
Biocon receives approval for Insulin Glargine in Mexico through its partner PiSA Farmaceutica
The combined market for Insulin Glargine in Mexico is estimated to be in excess of $40 million
Quintiles wins Best CRO Award at World Vaccine Congress 2015
For the third time in the last four years, Quintiles has been named Best Clinical Research Organization (CRO) at the Vaccine…
Plethico to pay Aurobindo Pharma $23.3 million to settle dispute
Aurobindo Pharma had emerged as the highest bidder for acquisition of Natrol Inc, US
Aurobindo Pharma receives US FDA approval
Atracurium Besylate injections are indicated as an adjunct to general anaesthesia
Biocon recognised for outstanding contribution to public health by WHO – India
Biocon's integrated healthcare initiatives is constantly engaged in improving the quality of life of several thousand communities…
DRL and its subsidiary Promius Pharma files three NDAs with US FDA
The three NDAs - DFD-01, DFD-09, and DFN-11, are in support of Dr Reddy’s Proprietary Products group